Skip to main content
Top
Published in: Infection 6/2010

01-12-2010 | Case Report

Surgical wound infection, tuboovarian abscess, and sepsis caused by Edwardsiella tarda: case reports and literature review

Authors: V. Golub, A. C. Kim, V. Krol

Published in: Infection | Issue 6/2010

Login to get access

Abstract

Edwardsiella tarda is a freshwater pathogen that may cause mild to invasive infections with high mortality in humans. We describe two patients with serious E. tarda infections. The first patient was a woman with a tuboovarian abscess (TOA) and bilateral salpingitis requiring surgical resection and drainage. Her hospital course was complicated by a postoperative wound infection. TOA fluid as well as surgical wound culture revealed pure growth of E. tarda resistant to several antibiotics. The second patient was a man with a bloodstream E. tarda infection and cholangitis who recently traveled to Ecuador. He presented with hypoxia and further workup revealed choledocholithiasis and common bile duct benign polyps. Both patients made a full recovery.
Literature
1.
go back to reference Winn W Jr, Allen S, Janda W, Koneman EW, Procarp GW, Schreckenberger PC, Woods GL. The enterobacteriaceae: color atlas and textbook of diagnostic microbiology, 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins 2006; pp 211–302. Winn W Jr, Allen S, Janda W, Koneman EW, Procarp GW, Schreckenberger PC, Woods GL. The enterobacteriaceae: color atlas and textbook of diagnostic microbiology, 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins 2006; pp 211–302.
2.
go back to reference Janda JM, Abbott SL. Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease. Clin Infect Dis. 1993;17:742–8.PubMed Janda JM, Abbott SL. Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease. Clin Infect Dis. 1993;17:742–8.PubMed
3.
go back to reference Nelson JJ, Nelson CA, Carter JE. Extraintestinal manifestations of Edwardsiella tarda infection: a 10-year retrospective review. J La State Med Soc. 2009;161:103–6.PubMed Nelson JJ, Nelson CA, Carter JE. Extraintestinal manifestations of Edwardsiella tarda infection: a 10-year retrospective review. J La State Med Soc. 2009;161:103–6.PubMed
4.
go back to reference Wyatt LE, Nickelson R 2nd, Vanderzant C. Edwardsiella tarda in freshwater catfish and their environment. Appl Environ Mircrobio. 1979;38:710–4. Wyatt LE, Nickelson R 2nd, Vanderzant C. Edwardsiella tarda in freshwater catfish and their environment. Appl Environ Mircrobio. 1979;38:710–4.
5.
go back to reference Janda JM, Abbott SL, Kroske-Bystrom S, Cheung WK, Powers C, Kokka RP, Tamura K. Pathogenic properties of Edwardsiella species. J Clin Microbiology. 1991;29:1997–2001. Janda JM, Abbott SL, Kroske-Bystrom S, Cheung WK, Powers C, Kokka RP, Tamura K. Pathogenic properties of Edwardsiella species. J Clin Microbiology. 1991;29:1997–2001.
6.
go back to reference Slaven EM, Lopez FA, Hart SM, Sanders CV. Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis. 2001;32:1430–3.CrossRefPubMed Slaven EM, Lopez FA, Hart SM, Sanders CV. Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis. 2001;32:1430–3.CrossRefPubMed
7.
go back to reference Stock I, Wiedemann B. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimibrob Agents Chemother. 2001;45:2245–55.CrossRef Stock I, Wiedemann B. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimibrob Agents Chemother. 2001;45:2245–55.CrossRef
8.
go back to reference Sechter I, Shmilovitz M, Altmann G, Seligmann R, Kretzer B, Braunstein I, Gerichter CB. Edwardsiella tarda isolated in Israel between 1961 and 1980. J Clin Microbiol. 1983;17:669–71.PubMed Sechter I, Shmilovitz M, Altmann G, Seligmann R, Kretzer B, Braunstein I, Gerichter CB. Edwardsiella tarda isolated in Israel between 1961 and 1980. J Clin Microbiol. 1983;17:669–71.PubMed
9.
go back to reference Pien FD, Jackson MT. Tuboovarian abscess caused by Edwardsiella tarda. Am J Obstet Gynecol. 1995;173:964–5.CrossRefPubMed Pien FD, Jackson MT. Tuboovarian abscess caused by Edwardsiella tarda. Am J Obstet Gynecol. 1995;173:964–5.CrossRefPubMed
10.
go back to reference Wang IK, Kuo HL, Chen YM, Lin CL, Chang HY, Chuang FR, Lee MH. Extraintestinal manifestations of Edwardsiella tarda infection. Int J Clin Pract. 2005;59:917–21.CrossRefPubMed Wang IK, Kuo HL, Chen YM, Lin CL, Chang HY, Chuang FR, Lee MH. Extraintestinal manifestations of Edwardsiella tarda infection. Int J Clin Pract. 2005;59:917–21.CrossRefPubMed
11.
go back to reference Yang CH, Wang CK. Edwardsiella tarda bacteraemia—complicated by acute pancreatitis and pyomyoma. J Infect. 1999;38:124–6.CrossRefPubMed Yang CH, Wang CK. Edwardsiella tarda bacteraemia—complicated by acute pancreatitis and pyomyoma. J Infect. 1999;38:124–6.CrossRefPubMed
12.
go back to reference Huang YC, Fracica PJ, Simonson SG, Crapo JD, Young SL, Welty-Wolf KE, Moon RE, Piantadosi CA. VA/Q abnormalities during gram negative sepsis. Respir Physiol. 1996;105(1–2):109–21.CrossRefPubMed Huang YC, Fracica PJ, Simonson SG, Crapo JD, Young SL, Welty-Wolf KE, Moon RE, Piantadosi CA. VA/Q abnormalities during gram negative sepsis. Respir Physiol. 1996;105(1–2):109–21.CrossRefPubMed
Metadata
Title
Surgical wound infection, tuboovarian abscess, and sepsis caused by Edwardsiella tarda: case reports and literature review
Authors
V. Golub
A. C. Kim
V. Krol
Publication date
01-12-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 6/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0057-5

Other articles of this Issue 6/2010

Infection 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine